✦ LIBER ✦

1P-0136 Effect of pioglitazone on atherogenic outcomes in patients with type 2 diabetes: Comparison with responder and non-responder groups

✍ Scribed by Jimbu, Y.; Igarashi, M.; Kimura, M.; Hirata, A.; Yamaguchi, H.; Kato, T.; Tominaga, M.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of pioglitazone on atherogenic ou

✍ Masahiko Igarashi; Yumi Jimbu; Minako Kimura; Akihiko Hirata; Hiroshi Yamaguchi; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 501 KB

Effect of ABCA1 variant on atherogenic d

✍ S. E. Park; E. S. Kang; D. H. Kim; S. K. Kim; J. H. Lee; C. W. Ahn; H. C. Lee; B 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB

We-P11:55 Pioglitazone and metformin hav

✍ Lawrence, J.M.; Reid, J.; Taylor, G.J.; Stirling, C.A.; Reckless, J.P.D. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 148 KB

Effect of pioglitazone on abdominal fat

✍ Yoshinori Miyazaki; Archana Mahankali; Masafumi Matsuda; Srikanth Mahankali; Ken 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 116 KB

Comparison of glycaemic control over 1 y

✍ G. Perriello; S. Pampanelli; C. Di Pietro; P. Brunetti; on behalf of the Italian 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 200 KB

Comparison of metabolic effects of piogl

✍ T. Yamanouchi; T. Sakai; K. Igarashi; K. Ichiyanagi; H. Watanabe; T. Kawasaki 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 182 KB